✦ LIBER ✦

Impact of peginterferon alpha-2b and ribavirin treatment on liver tissue in patients with HCV or HCV–HIV co-infection

✍ Scribed by Rui Sarmento-Castro; Ana Horta; Olga Vasconcelos; Helena Coelho; Josefina Mendez; Ana Paula Tavares; João Seabra; Manuela Duarte; Leonor Chaves; Olga Fortes; Cristina Recalde; Ângela Ventura; Nuno Pires; Luciana Pinho; Nancy Dias; Fátima Carneiro

Book ID: 108174454
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 205 KB
Volume: 54
Category: Article
ISSN: 0163-4453
DOI: 10.1016/j.jinf.2006.11.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of HCV infection with interfer

Treatment of HCV infection with interferon alpha-2b and ribavirin in a patient with X-linked lymphoproliferative syndrome

✍ Nicola Strnad-Trojan; Richard Linde; Janine Reichenbach; Jörg Trojan; Stefan Zeu 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 89 KB

Predicting treatment outcome following 2

Predicting treatment outcome following 24 weeks peginterferon α-2a/ribavirin therapy in patients infected with HCV genotype 1: Utility of HCV-RNA at day 0, day 22, day 29, and week 6

✍ Esther Lukasiewicz; Kristoffer Hellstrand; Johan Westin; Carlo Ferrari; Avidan U 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

We sought to validate FIB-4 using data retrospectively collected from treatment-naive HIV/HCV patients. The original model was adapted in order to use AST and ALT levels expressed as times the upper limit of normality (ϫULN), as follows: (age [yr] ϫ AST [ϫULN]) ϫ 10/((PLT [10 9 /l]) ϫ (ALT [ϫULN]) 1

Predictive value of early viral dynamics

Predictive value of early viral dynamics during peginterferon and ribavirin combination therapy based on genetic polymorphisms near the IL28B gene in patients infected with HCV genotype 1b

✍ Hidenori Toyoda; Takashi Kumada; Toshifumi Tada; Kazuhiko Hayashi; Takashi Honda 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB 👁 1 views

## Abstract A study was carried out to determine whether early viral dynamics retain prediction of the outcome of peginterferon (PEG‐IFN) and ribavirin combination therapy based on different genetic polymorphisms near the __IL28B__ gene, the strongest baseline predictor of response to this therapy.

Impact of IL28B on treatment outcome in

Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)/ribavirin

✍ Thomas-Matthias Scherzer; Albert Friedrich Stättermayer; Michael Strasser; Herma 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 502 KB

The IL28B genotype is the most important pretreatment predictor of treatment outcome in patients with chronic hepatitis C. The impact of the rs12979860 genotype on relapse was retrospectively evaluated in genotype 1/4 patients who received response-guided therapy with peginterferon alpha-2a 180 μg/w